Literature DB >> 12186496

Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma.

S Wang1, R V Lloyd, M J Hutzler, I B Rosenwald, M S Safran, N A Patwardhan, A Khan.   

Abstract

Cell growth and proliferation depend on protein synthesis that is regulated, in part, by two eukaryotic translation initiation factors, eIF-4E and eIF-2alpha. These factors are transiently increased as normal cells respond to growth factors and are constitutively elevated in transformed cells. In cultured cells, eIF-4E facilitates cell cycle progression by increasing the expression of cell cycle promoting proteins including cyclin D1. Our previous study revealed elevated cyclin D1 expression in histologically more aggressive thyroid carcinomas as compared to conventional papillary carcinoma. We hypothesized that the increased cyclin D1 expression might correlate with increased eIF-4E expression. We, therefore studied the expression of eIF-4E by immunohistochemistry in 25 cases of conventional papillary carcinoma (CPC) and 28 cases of aggressive thyroid carcinomas (ATC), the latter included 11 tall cell/columnar cell variant of papillary carcinoma, 5 insular carcinomas, and 12 anaplastic carcinomas. We also analyzed the expression of eIF-2a in the same samples as this factor is usually regulated similarly to eIF-4E in cell culture models. Of the 25 CPC, 13 were eIF-4E positive (11 weakly and 2 strongly), and 19 were eIF-2a positive (14 weakly and 5 strongly). Conversely, of the 28 ATC, 25 were eIF-4E positive (4 weakly and 21 strongly), and 23 were eIF-2alpha positive (4 weakly and 19 strongly). There was a significantly increased expression of both eIF-4E (p < 0.001) and eIF-2alpha (p < 0.001) in ATC compared to CPC, suggesting that these translation initiation factors may play a role in the progression of thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12186496     DOI: 10.1089/10507250152740939

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  17 in total

Review 1.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 2.  Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?

Authors:  Katherine L B Borden; Biljana Culjkovic-Kraljacic
Journal:  Leuk Lymphoma       Date:  2010-10

Review 3.  The biological and therapeutic relevance of mRNA translation in cancer.

Authors:  Sarah P Blagden; Anne E Willis
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

Review 4.  Targeting the unfolded protein response in head and neck and oral cavity cancers.

Authors:  Daniel W Cole; Peter F Svider; Kerolos G Shenouda; Paul B Lee; Nicholas G Yoo; Thomas M McLeod; Sean A Mutchnick; George H Yoo; Randal J Kaufman; Michael U Callaghan; Andrew M Fribley
Journal:  Exp Cell Res       Date:  2019-05-07       Impact factor: 3.905

5.  Celastrol induces unfolded protein response-dependent cell death in head and neck cancer.

Authors:  Andrew M Fribley; Justin R Miller; Amy L Brownell; Danielle M Garshott; Qinghua Zeng; Tyler E Reist; Neha Narula; Peter Cai; Yue Xi; Michael U Callaghan; Vamsi Kodali; Randal J Kaufman
Journal:  Exp Cell Res       Date:  2014-08-17       Impact factor: 3.905

6.  Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein response.

Authors:  Andrew M Fribley; Patricia G Cruz; Justin R Miller; Michael U Callaghan; Peter Cai; Neha Narula; Richard R Neubig; Hollis D Showalter; Scott D Larsen; Paul D Kirchhoff; Martha J Larsen; Douglas A Burr; Pamela J Schultz; Renju R Jacobs; Giselle Tamayo-Castillo; David Ron; David H Sherman; Randal J Kaufman
Journal:  J Biomol Screen       Date:  2011-08-15

7.  Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors.

Authors:  Magdalena Slosar; Poonam Vohra; Manju Prasad; Andrew Fischer; Robert Quinlan; Ashraf Khan
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

8.  Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors.

Authors:  Sonia Tejada; M Val T Lobo; Mercedes García-Villanueva; Silvia Sacristán; M Isabel Pérez-Morgado; Matilde Salinas; M Elena Martín
Journal:  J Histochem Cytochem       Date:  2009-02-02       Impact factor: 2.479

Review 9.  Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.

Authors:  J Musa; M F Orth; M Dallmayer; M Baldauf; C Pardo; B Rotblat; T Kirchner; G Leprivier; T G P Grünewald
Journal:  Oncogene       Date:  2016-02-01       Impact factor: 9.867

10.  Tumor suppression by small molecule inhibitors of translation initiation.

Authors:  Limo Chen; Bertal H Aktas; Yibo Wang; Xiaoying He; Rupam Sahoo; Nancy Zhang; Severine Denoyelle; Eihab Kabha; Hongwei Yang; Revital Yefidoff Freedman; Jeffrey G Supko; Michael Chorev; Gerhard Wagner; Jose A Halperin
Journal:  Oncotarget       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.